Keenova Therapeutics plc Other Current Liabilities
Keenova Therapeutics plc had Other Current Liabilities of $170.30 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Other Liabilities, Current $170.30M.
- 2026-03-31: Other Liabilities, Current $170.10M.
- 2025-12-31: Other Liabilities, Current $165.80M.
- 2025-09-26: Other Liabilities, Current $305.90M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $170.30M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $170.10M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $165.80M 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $305.90M 10-Q · filed 2025-11-10 | |
| 2025-06-27 | $250.60M 10-Q · filed 2025-08-06 | |
| 2025-03-28 | $274.50M 10-Q · filed 2025-05-12 | |
| 2024-12-27 | $90.40M 10-K · filed 2026-04-15 | $231.10M 10-K · filed 2025-03-13 |
| 2024-09-27 | $280.10M 10-Q · filed 2024-11-05 | |
| 2024-06-28 | $292.20M 10-Q · filed 2024-08-06 | |
| 2024-03-29 | $279.10M 10-Q · filed 2024-05-09 | |
| 2023-12-29 | $269.90M 10-K · filed 2025-03-13 | |
| 2023-09-29 | $243.70M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $256.80M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $234.50M 10-Q · filed 2023-05-09 | |
| 2022-12-30 | $290.70M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $317.60M 10-Q · filed 2022-11-08 | |
| 2022-07-01 | $326.50M 10-Q · filed 2022-08-11 | |
| 2022-04-01 | $269.90M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $328.70M 10-K · filed 2023-03-03 | |
| 2021-09-24 | $387.10M 10-Q · filed 2021-11-02 | |
| 2021-06-25 | $372.50M 10-Q · filed 2021-08-03 | |
| 2021-03-26 | $357.20M 10-Q · filed 2021-05-04 | |
| 2020-12-25 | $331.20M 10-K · filed 2022-03-15 | |
| 2020-09-25 | $381.00M 10-Q · filed 2020-11-03 | |
| 2020-06-26 | $375.50M 10-Q · filed 2020-08-04 | |
| 2020-03-27 | $394.40M 10-Q · filed 2020-05-06 | |
| 2019-12-27 | $485.40M 10-K · filed 2021-03-10 | |
| 2019-09-27 | $506.50M 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $565.30M 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $560.70M 10-Q · filed 2019-05-07 | |
| 2018-12-28 | $572.20M 10-K · filed 2020-02-26 | $547.20M 10-K · filed 2019-02-26 |
| 2018-09-28 | $437.50M 10-Q · filed 2018-11-06 | |
| 2018-06-29 | $441.00M 10-Q · filed 2018-08-07 | |
| 2018-03-30 | $368.00M 10-Q · filed 2018-05-08 | |
| 2017-12-29 | $452.10M 10-K · filed 2019-02-26 | |
| 2017-09-29 | $440.40M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $460.20M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $525.80M 10-Q · filed 2017-05-08 | |
| 2016-12-30 | $557.10M 10-K · filed 2018-02-27 | $658.80M 10-QT · filed 2017-02-07 |
| 2016-09-30 | $550.90M 10-QT · filed 2017-02-07 | |
| 2016-06-24 | $642.00M 10-Q · filed 2016-08-02 | |
| 2016-03-25 | $549.50M 10-Q · filed 2016-05-03 | |
| 2015-12-25 | $592.50M 10-Q · filed 2016-02-02 | |
| 2015-09-25 | $486.10M 10-K · filed 2016-11-29 | $568.30M 10-K · filed 2015-11-24 |
| 2015-06-26 | $476.80M 10-Q · filed 2015-08-04 | |
| 2015-03-27 | $508.30M 10-Q · filed 2015-05-05 | |
| 2014-12-26 | $505.90M 10-Q · filed 2015-02-03 | |
| 2014-09-26 | $529.90M 10-K · filed 2015-11-24 | $546.70M 10-K · filed 2014-11-25 |
| 2014-06-27 | $400.90M 10-Q · filed 2014-08-07 | |
| 2014-03-28 | $403.10M 10-Q · filed 2014-05-08 | |
| 2013-12-27 | $337.90M 10-Q · filed 2014-02-07 | |
| 2013-09-27 | $363.50M 8-K · filed 2015-04-03 | $376.70M 10-K · filed 2013-12-13 |
| 2013-06-28 | $381.30M 10-Q · filed 2013-08-12 | |
| 2012-09-28 | $221.70M 10-K · filed 2013-12-13 | $282.00M 10-Q · filed 2013-08-12 |